Johns Hopkins-Luminox deal sets up accelerator for Israeli digital health startups

Johns Hopkins Technology Ventures has inked a multiyear agreement with Israeli digital health business Luminox that will set up an accelerator for Israeli digital health startups,

Cross border deals involving digital health startups in Israel are on the rise. In the most recent example, Johns Hopkins Technology Ventures has inked a multiyear agreement with Israeli digital health business Luminox that will set up an accelerator for Israeli digital health startups, among other things.

Luminox refers to itself as a digital health hub. It helps connect early stage companies with U.S. institutions, corporates and strategic partners.

As part of the deal, Luminox will set up an investment fund focused on early-stage digital health technology that will collaborate with FastForward — Johns Hopkins’ technology accelerator, according to a statement from Johns Hopkins. The collaboration will help commercialize products for the U.S. market. Luminox companies will work on research with Johns Hopkins faculty, who will co-develop those startups with Israeli entrepreneurs through the university’s HexciteIL initiative.

HexciteIL is a program that pairs Johns Hopkins medical, computer science, and engineering faculty with startups in an intensive, three-month program to identify technology applications, co-develop IP, do prototyping, and conduct sponsored research. It will be offered through the Johns Hopkins Medicine Technology Innovation Center, which is part of Fast Forward East.

They will also be eligible to participate in the entrepreneur in residence program.

Johns Hopkins is also in discussions with strategic players across the health insurance, pharmaceutical and retail sectors. The idea is for them to collaborate with the digital health entrepreneurs in the program.

Photo: Johns Hopkins Technology Ventures